26 companies

Celon Pharma

Market Cap: zł1.1b

An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.

CLN

zł20.70

7D

-0.5%

1Y

-12.5%

Selvita

Market Cap: zł611.2m

Provides drug discovery, drug development, and contract testing services in Poland.

SLV

zł33.30

7D

4.7%

1Y

-4.3%

Ryvu Therapeutics

Market Cap: zł523.7m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł22.65

7D

-3.0%

1Y

-30.6%

Captor Therapeutics Spolka Akcyjna

Market Cap: zł497.5m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

CTX

zł78.30

7D

0.4%

1Y

115.1%

Bioceltix

Market Cap: zł403.3m

Engages in the development of stem cell-based biopharmaceuticals for veterinary use.

BCX

zł81.90

7D

-2.2%

1Y

-28.8%

BIOTON

Market Cap: zł372.7m

A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.

BIO

zł4.34

7D

1.2%

1Y

5.1%

Syn2bio

Market Cap: zł288.1m

A biotechnology company, engages in the research and commercialization of Cardiac Marker, a radiopharmaceutical for diagnostic testing of heart disease in the field of myocardial perfusion.

S2B

zł33.00

7D

14.4%

1Y

n/a

Synthaverse

Market Cap: zł212.0m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.

SVE

zł3.00

7D

-4.9%

1Y

-46.8%

Mabion

Market Cap: zł119.9m

A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.

MAB

zł7.42

7D

-3.6%

1Y

-26.5%

Molecure

Market Cap: zł110.0m

A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.

MOC

zł5.34

7D

1.1%

1Y

-36.0%

NanoGroup

Market Cap: zł101.0m

Operates as a biotechnology company in Poland.

NNG

zł2.37

7D

-1.3%

1Y

-23.5%

Genomtec

Market Cap: zł91.7m

Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

GMT

zł6.09

7D

-4.2%

1Y

-16.0%

Poltreg

Market Cap: zł90.9m

A biotechnology company, researches and develops therapies for autoimmune diseases.

PTG

zł19.50

7D

12.4%

1Y

-45.5%

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

HEN

zł2.32

7D

0%

1Y

-34.6%

Urteste

Market Cap: zł62.3m

Engages in the research and development of diagnostic tests for cancers.

URT

zł44.20

7D

4.2%

1Y

-46.1%

Read-Gene

Market Cap: zł62.3m

Engages in the detection, prevention, and treatment of various types of cancer.

RDG

zł5.28

7D

3.9%

1Y

22.8%

Biogened

Market Cap: zł44.5m

Produces and sells cosmetics and toiletries in Poland.

BGD

zł18.10

7D

-7.2%

1Y

-40.8%

Medicofarma Biotech

Market Cap: zł33.2m

Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.

MDB

zł0.49

7D

16.2%

1Y

84.2%

Genomed Spólka Akcyjna

Market Cap: zł31.7m

Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.

GEN

zł24.00

7D

-5.5%

1Y

0%

Pure Biologics

Market Cap: zł23.5m

A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.

PUR

zł1.92

7D

-20.3%

1Y

-77.2%

genXone

Market Cap: zł19.8m

Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.

GX1

zł6.00

7D

0%

1Y

-3.8%

Stem Cells Spin

Market Cap: zł18.2m

Operates as a biotechnology company in Poland.

SCS

zł0.44

7D

10.0%

1Y

134.0%

Green Zebras Spolka Akcyjna

Market Cap: zł12.2m

Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.

GRZ

zł7.70

7D

2.7%

1Y

-16.8%

Cannabis Poland

Market Cap: zł8.9m

Operates in the medical cannabis industry in Poland.

CBD

zł0.18

7D

-1.6%

1Y

-46.3%

Tecnovatica

Market Cap: zł7.9m

Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.

TEC

zł0.74

7D

13.9%

1Y

67.7%

Labocanna

Market Cap: zł4.4m

Engages in the cultivation, production, and distribution of hemp product.

LCN

zł0.21

7D

0.5%

1Y

-36.9%